scholarly journals Long‐term survival following elective colon cancer surgery in the aged. A population‐based cohort study

2020 ◽  
Vol 22 (11) ◽  
pp. 1585-1596
Author(s):  
S. Niemeläinen ◽  
H. Huhtala ◽  
A. Ehrlich ◽  
J. Kössi ◽  
E. Jämsen ◽  
...  

Surgery ◽  
2021 ◽  
Author(s):  
Arvid Pourlotfi ◽  
Rebecka Ahl Hulme ◽  
Maximilian Peter Forssten ◽  
Gabriel Sjolin ◽  
Gary A. Bass ◽  
...  


2012 ◽  
Vol 255 (6) ◽  
pp. 1126-1128 ◽  
Author(s):  
Malin E. M. Mörner ◽  
Ulf Gunnarsson ◽  
Pia Jestin ◽  
Monika Svanfeldt


2008 ◽  
Vol 107 (1) ◽  
pp. 325-332 ◽  
Author(s):  
Rose Christopherson ◽  
Kenneth E. James ◽  
Mara Tableman ◽  
Prudence Marshall ◽  
Frank E. Johnson


2007 ◽  
Vol 205 (3) ◽  
pp. S78
Author(s):  
Rose Christopherson ◽  
Kenneth James ◽  
Mara Tableman ◽  
Prudence Marshall ◽  
Frank Johnson


BMJ Open ◽  
2014 ◽  
Vol 4 (3) ◽  
pp. e004648 ◽  
Author(s):  
Maartje van der Schaaf ◽  
Maryam Derogar ◽  
Asif Johar ◽  
Martin Rutegård ◽  
James Gossage ◽  
...  


BMJ ◽  
2018 ◽  
pp. k1998 ◽  
Author(s):  
Niels Obel ◽  
Ram B Dessau ◽  
Karen A Krogfelt ◽  
Jacob Bodilsen ◽  
Nanna S Andersen ◽  
...  


2020 ◽  
Author(s):  
Yun-Xiao Zhang ◽  
Dong-Liang Mu ◽  
Ke-Min Jin ◽  
Xue-Ying Li ◽  
Dong-Xin Wang

Abstract Background Perioperative anesthetic management may affect long-term outcome after cancer surgery. This study aimed to investigate the effect of perioperative glucocorticoids on long-term survival in patients after radical resection for pancreatic cancer.Methods In this retrospective cohort study, patients who underwent radical resection for pancreatic cancer from January 2005 to December 2016 were recruited. Baseline and perioperative data including use of glucocorticoids for prevention of postoperative nausea and vomiting were collected. Patients were followed up for tumor recurrence and survival. The primary outcome was the overall survival (OS); the secondary outcome was the recurrence-free survival (RFS). A multivariable Cox proportional hazard model was used to analyze the influence of perioperative glucocorticoid use on OS and RFS after correction for confounding factors.Results A total of 215 patients after radical surgery for pancreatic cancer were included in the study; of these, 112 received perioperative glucocorticoids and 103 did not. Patients were followed up for a median of 74.0 months (95% confidence interval [CI] 68.3-79.7). Both OS and RFS were significantly longer in patients with glucocorticoids than in those without (for OS: median 19.7 months [95% CI 12.3-36.2] vs. 13.9 months [8.0-23.9], P=0.001; for RFS: 12.0 months [6.0-28.0] vs. 6.9 months [4.2-17.0], P=0.002). After correction for confounding factors, perioperative glucocorticoids were significantly associated with prolonged OS (HR 0.692, 95% CI 0.499-0.959, P=0.027) and RFS (HR 0.634, 95% CI 0.459-0.878, P=0.006).Conclusions Perioperative use of low-dose glucocorticoids may improve long-term survival in patients undergoing radical surgery for pancreatic cancer.



2017 ◽  
Vol 138 (2) ◽  
pp. 183-189 ◽  
Author(s):  
Teresia Svanvik ◽  
Karin Sundfeldt ◽  
Ulf Strömberg ◽  
Erik Holmberg ◽  
Janusz Marcickiewicz


Sign in / Sign up

Export Citation Format

Share Document